We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$348M
AUM Growth
+$51.1M
Cap. Flow
+$11.6M
Cap. Flow %
3.35%
Top 10 Hldgs %
32.79%
Holding
156
New
12
Increased
53
Reduced
49
Closed
4

Top Buys

Rank Stock Value
1
VTV icon
Vanguard Morningstar Value ETF
VTV
+$1.63M
2
EW icon
Edwards Lifesciences
EW
+$1.32M
3
MSFT icon
Microsoft
MSFT
+$1.15M
4
SCHP icon
Schwab US TIPS ETF
SCHP
+$881K
5
TMO icon
Thermo Fisher Scientific
TMO
+$849K

Top Sells

Rank Stock Value
1
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
+$459K
2
EPR icon
EPR Properties
EPR
+$403K
3
GFF icon
Griffon
GFF
+$258K
4
SPLK
Splunk Inc
SPLK
+$207K
5
SPGI icon
S&P Global
SPGI
+$206K

Sector Composition

Rank Sector Weight
1 Healthcare 17.86%
2 Technology 13.26%
3 Consumer Staples 11.19%
4 Financials 10.19%
5 Communication Services 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFS icon
151
OFS Capital
OFS
$50.4M
$100K 0.03%
14,000
-3,750
-21% -$21.6K
NOK icon
152
Nokia
NOK
$52.8B
$59K 0.02%
15,000
-1,000
-6% -$3.94K
EPR icon
153
EPR Properties
EPR
$4.72B
– –
-14,650
Closed -$403K
SPGI icon
154
S&P Global
SPGI
$120B
– –
-570
Closed -$206K
SPLK
155
DELISTED
Splunk Inc
SPLK
– –
-1,100
Closed -$207K
BSX.PRA
156
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
– –
-4,100
Closed -$459K
3 4 5 6
7

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
OC
Oarsman Capital Milwaukee, Wisconsin $806M AUM 19.96% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return

Kavar Capital Partners Group's Q4 2020 Portfolio in Review

As of Q4 2020, Kavar Capital Partners Group held 156 positions worth $348M, up 17% from $297M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kavar Capital Partners Group deployed $11.6M of net new capital in Q4 2020, opening 12 new positions and adding to 53 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 14,484 shares worth $1.72M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Griffon, an estimated $258K trimmed.

  • Kavar Capital Partners Group's largest Q4 2020 buy was Vanguard Morningstar Value ETF: 14,484 shares worth $1.72M.
  • Kavar Capital Partners Group added most to Edwards Lifesciences in Q4 2020, an estimated $1.32M increase.
  • Kavar Capital Partners Group's biggest Q4 2020 reduction was Griffon, cutting an estimated $258K.
  • Kavar Capital Partners Group fully exited Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2020, selling an estimated $459K.
  • Kavar Capital Partners Group's ten largest holdings make up 33% of its $348M portfolio in Q4 2020.
  • Kavar Capital Partners Group opened 12 new positions and closed 4 in Q4 2020.
  • Kavar Capital Partners Group's portfolio value rose 17% quarter-over-quarter to $348M.

Based on Kavar Capital Partners Group's 13F filing for Q4 2020, filed 5 Feb 2021.